Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
TVRD Stock — Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. (TVRD)
Updated October 16, 2026.
TVRD is a Stock. Total return is -99.8% over the past 12.7 years, 529.8 points behind SPY at 430.0%.
Tvardi Therapeutics is a clinical-stage biopharmaceutical company developing oral, small-molecule therapies that target STAT3 to treat inflammatory and proliferative diseases, with lead candidates in early-stage clinical trials for conditions including idiopathic pulmonary fibrosis and hepatocellular carcinoma. The company does not currently pay distributions. This security may appeal to investors seeking exposure to early-stage drug development with high risk and potential for significant capital appreciation if clinical programs advance successfully.
TVRD performance versus SPY
Price and return data through 2026-10-16.
Total return is -99.8% over the past 12.7 years, 529.8 points behind SPY at 430.0%. Over the past year its total return — price change plus distributions reinvested — is -84.4%. Its deepest 1-year drawdown was 84.8%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -41.6% | — |
| 3M | -67.2% | — |
| 6M | -68.6% | — |
| YTD | -76.5% | — |
| 1Y | -84.4% | — |
| 2Y CAGR | — | -67.50% |
| 3Y CAGR | — | -73.50% |
| 5Y CAGR | — | -70.80% |
| 10Y CAGR | — | -43.00% |
| Since inception (12.7 years) | -99.8% | -38.30% |
TVRD key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 01/31/2014
- Distribution frequency
- None
- Last close
- $1.01 (as of 2026-10-16)
- Market cap
- $13,472,332
- Average volume
- 91719.0
- Payout ratio
- 0.0%
- EPS
- $-2.88
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
TVRD risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 84.8%.
Who may consider TVRD — and who may not
It is a weaker fit for investors who need monthly cash flow (TVRD does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on TVRD
Frequently asked questions
Does TVRD pay monthly?
No. TVRD does not currently distribute.
When does TVRD pay a dividend?
TVRD does not currently distribute.
How has TVRD performed?
Total return is -99.8% over the past 12.7 years, 529.8 points behind SPY at 430.0%. Over the past year its total return — price change plus distributions reinvested — is -84.4%. Its deepest 1-year drawdown was 84.8%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.